Cognition Therapeutics Initiates Patient Dosing in Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer’s Disease
Press Release
, November 8th, 2018
About: dhartzell@elias-savion.com
Recent Posts by dhartzell@elias-savion.com
Wellbridge Health Unveils First-of-its-Kind Digital Care Management Program for End-Stage Renal Disease: No-Risk Pilot Ready for Insurers and Employers
Press Release
, November 1st, 2018
Cognition Therapeutics to Sponsor Third International Symposium on Sigma-2 Receptors: Role in Health and Disease during the Society for Neuroscience Annual Meeting
Press Release
, October 24th, 2018
Cognition Therapeutics Receives $16.6 Million Multiyear NIA Grant for Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer’s Disease
Intrado
, October 2nd, 2018
Medrobotics touts first EU sale of Flex robotic platform
Mass Device
, October 1st, 2018
Complexa Presents Data Evaluating the Pharmacological Action of CXA-10 on Drug-metabolizing Transport Proteins at 2018 American College of Clinical Pharmacology Annual Meeting
Press Release
, September 24th, 2018
Wellbridge Health, Inc. Works with Pittsburgh Business Group on Health to Lower Health Care Costs for Employers
Press Release
, September 20th, 2018
New Flexible Robotic Scope Enables Physicians to Remove Large Colorectal Lesions without Surgery
Press Release
, September 7th, 2018
Pivotal Trial of ALung’s Artificial Lung Technology Reaches Record Enrollment
Press Release
, September 4th, 2018
Complexa Names Theodore Danoff, MD, PhD, Chief Medical Officer
Press Release
, August 19th, 2018
Recent Comments by dhartzell@elias-savion.com
No comments by dhartzell@elias-savion.com yet.